Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.

Meyer, Sarah A; Novak, Ryan T

Meyer, Sarah A; Novak, Ryan T.

Affiliation

Meyer SA; Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: vif6@cdc.gov.
Novak RT; Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Lancet Infect Dis ; 17(8): 789-790, 2017 08.

Article in En | MEDLINE | ID: mdl-28545720

Subject(s)

Neisseria meningitidis/immunology; Serogroup; Africa; Epidemics; Humans; Meningitis, Meningococcal/epidemiology; Meningococcal Vaccines; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serogroup / Neisseria meningitidis Limits: Humans Country/Region as subject: Africa Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google